2025
Community Connectedness as a Source of Adherence to HIV Prevention Behaviors and Resilience Among Transgender Women of Color in New York City, 2020-2022.
Furuya A, Ransome Y, Kawachi I, Callander D, Radix A, Whalen A, Herrera C, Watson K, Contreras J, Merriman J, Bhatt K, Scheinmann R, Lim S, Trinh-Shevrin C, Schneider J, Park S, Duncan D. Community Connectedness as a Source of Adherence to HIV Prevention Behaviors and Resilience Among Transgender Women of Color in New York City, 2020-2022. American Journal Of Public Health 2025, 115: 1631-1641. PMID: 40929666, PMCID: PMC12424489, DOI: 10.2105/ajph.2025.308144.Peer-Reviewed Original ResearchConceptsSexually transmitted infectionsTransgender women of colorHIV prevention behaviorsCommunity connectednessTransgender womenWomen of colorHIV preventionPreventive behaviorsNew York CityPreexposure prophylaxis useHIV viral load suppressionViral load suppressionFeelings of isolationCare continuumCare outcomesYork CityCaring behaviorsFuture interventionsSources of resilienceFeelings of inclusionTransgender communityCondom usageProphylaxis useFeelings of connectionTransgender
2023
Leveraging family-based assets for Black men who have sex with men in House Ball Communities: Protocol for a cluster randomized controlled trial
Birnbaum J, Roberson M, Bailey M, Smith M, Turner D, Qian H, Jeon S, Hirshfield S, Nelson L. Leveraging family-based assets for Black men who have sex with men in House Ball Communities: Protocol for a cluster randomized controlled trial. PLOS ONE 2023, 18: e0289681. PMID: 37683036, PMCID: PMC10490903, DOI: 10.1371/journal.pone.0289681.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHouse Ball CommunityHBC familiesBlack MSMBall CommunityHIV-negative Black MSMHIV-positive Black MSMHIV pre-exposure prophylaxis (PrEP) usePre-exposure prophylaxis useNew human immunodeficiency virusADAPT-ITT modelWaitlist control armCondomless anal intercourseFamily-based interventionsBlack menProphylaxis useHIV careHIV-negativeSecondary outcomesHIV testingPrimary outcomeImmunodeficiency virusHIV treatmentPreliminary efficacyControl armHIV risk profile and prevention needs of individuals seeking monkeypox (mpox) vaccination in an urban clinic in the U.S.: a brief report
Ogbuagu O, Sharma M, Igiraneza G, Andrews L, Tuan J, Barakat L. HIV risk profile and prevention needs of individuals seeking monkeypox (mpox) vaccination in an urban clinic in the U.S.: a brief report. BMC Infectious Diseases 2023, 23: 146. PMID: 36890468, PMCID: PMC9993362, DOI: 10.1186/s12879-023-08075-5.Peer-Reviewed Original ResearchConceptsHIV risk profilesSTI riskPre-exposure prophylaxis useRisk profileMedian age 28 yearsHIV-negative respondentsHIV-negative participantsHIV-negative individualsReceptive anal intercourseModerate alcohol useAge 28 yearsCross-sectional surveySexual partner numberProphylaxis useResultsEighty-onePrEP knowledgeHIV positivityPrevention gapUrban clinicCenter clinicPrevention needsSTI historyInclusion criteriaAnal intercourseIllicit substances
2020
Willingness to Use Pre-Exposure Prophylaxis (PrEP) for HIV Prevention and PrEP Implementation Preferences Among Transgender Women in Malaysia
Galka JM, Wang M, Azwa I, Gibson B, Lim SH, Shrestha R, Wickersham JA. Willingness to Use Pre-Exposure Prophylaxis (PrEP) for HIV Prevention and PrEP Implementation Preferences Among Transgender Women in Malaysia. Transgender Health 2020, 5: 258-266. PMID: 33644315, PMCID: PMC7906238, DOI: 10.1089/trgh.2020.0003.Peer-Reviewed Original ResearchPre-exposure prophylaxisHIV preventionTransgender womenWorld Health Organization indicationsEffective HIV prevention strategiesDelivery of PrEPHigh HIV burdenInjection drug useHIV prevention strategiesMalaysian adult populationProphylaxis useHIV burdenHormone usePrEP willingnessHigh school educationPrevention strategiesDrug useAdult populationOlder ageSubstance abusePrEPMultivariate modelChinese ethnicityMost participantsPrevention
2019
Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease
Faye AS, Hung KW, Cheng K, Blackett JW, Mckenney AS, Pont AR, Li J, Lawlor G, Lebwohl B, Freedberg DE. Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019, 26: 1394-1400. PMID: 31689354, PMCID: PMC7534414, DOI: 10.1093/ibd/izz269.Peer-Reviewed Original ResearchConceptsInflammatory bowel diseaseVTE prophylaxisProphylaxis ratesVenous thromboembolismBowel diseaseVTE prophylaxis ratesVTE prophylaxis useBlood transfusion rateRetrospective cohort studyVenous thromboembolism prophylaxisStrong independent predictorExposure of interestChronic bleedingProphylaxis useThromboembolism prophylaxisTransfusion rateCohort studyHospitalized patientsIndependent predictorsPrimary outcomeHemoglobin levelsMedical recordsHematocheziaProphylaxisPatients
2017
Prophylaxis use among males with haemophilia B in the United States
Ullman M, Zhang Q, Grosse S, Recht M, Soucie J, Investigators T. Prophylaxis use among males with haemophilia B in the United States. Haemophilia 2017, 23: 910-917. PMID: 28780772, PMCID: PMC5724962, DOI: 10.1111/hae.13317.Peer-Reviewed Original ResearchConceptsProphylaxis useBody mass indexAbove-normal body mass indexProphylactic treatmentCenters for Disease Control and Prevention's Universal Data Collection projectHemophilia B (HBModerate to severe hemophiliaHealth care coverageSample of personsB (HBAssociated with younger ageHaemophilia treatment centresCare coverageSelf-infusionHispanic ethnicityClinical characteristicsHemophilia ATreatment patternsOptimal treatmentSevere haemophiliaHemophilia BInfluence accessMass indexUnited StatesFactor concentrations
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply